Disease-modifying therapies in systemic lupus erythematosus for extrarenal manifestations Anca D Askanase, Richard A Furie, Maria Dall'Era, Andrew S Bomback, Andreas Schwarting, Ming-Hui Zhao, Ian N Bruce, Munther Khamashta, Bernie Rubin, Angela Carroll, Mark Daniels, Roger Abramino Levy, Ronald van Vollenhoven, Murray B Urowitz
22 May 2024
Clinical trial outcomes for SLE: what we have and what we need Laurent Arnaud, Ioannis Parodis, Hervé Devilliers, Francois Chasset
15 February 2024
Interferon pathway in SLE: one key to unlocking the mystery of the disease Lars Rönnblom, Dag Leonard
19 January 2024
Mezagitamab in systemic lupus erythematosus: clinical and mechanistic findings of CD38 inhibition in an autoimmune disease Scott R P McDonnell, Van Anh Nguyen, Noah M Walton, Carsten Merkwirth, Feng Hong, Deborah Berg, Elena Tomaselli Muensterman, Richard A Furie
7 March 2024
Rituximab as an effective add-on maintenance therapy for disease activities in childhood-onset systemic lupus erythematosus Ting-Wei Lin, Yu-Tsan Lin, Ya-Chiao Hu, Hsin-Hui Yu, Bor-Luen Chiang
19 January 2024
Evaluation of RNase therapy in systemic lupus erythematosus: a randomised phase 2a clinical trial of RSLV-132 Daniel J Burge, Victoria P Werth, Susan A Boackle, James Posada
7 February 2024
Scoring systemic lupus erythematosus (SLE) disease activity with simple, rapid outcome measures Aikaterini Thanou, Judith A James, Cristina Arriens, Teresa Aberle, Eliza Chakravarty, Joseph Rawdon, Stavros Stavrakis, Joan T Merrill, Anca Askanase
19 January 2024
Systemic lupus in the era of machine learning medicine Kevin Zhan, Katherine A Buhler, Irene Y Chen, Marvin J Fritzler, May Y Choi
4 March 2024
Therapeutic drug monitoring of mycophenolic acid and clinical outcomes of lupus nephritis: a systematic review and meta-analysis Thunyatorn Wuttiputhanun, Nuanjanthip Naiyarakseree, Suwasin Udomkarnjananun, Wonngarm Kittanamongkolchai, Leelahavanichkul Asada, Pajaree Chariyavilaskul, Natavudh Townamchai, Yingyos Avihingsanon
17 January 2024
Correction of omega-3 fatty acid deficiency and improvement in disease activity in patients with systemic lupus erythematosus treated with krill oil concentrate: a multicentre, randomised, double-blind, placebo-controlled trial Jane Salmon, Daniel J Wallace, Violeta Rus, Addison Cox, Claire Dykas, Brooke Williams, Yunpeng Ding, Petter-Arnt Hals, Line Johnsen, Peter E Lipsky
14 July 2024
Fragility of randomised controlled trials for systemic lupus erythematosus and lupus nephritis therapies Gabriel Figueroa-Parra, Michael S Putman, Cynthia S Crowson, Alí Duarte-García
10 January 2024
Changing paradigms in the treatment of systemic lupus erythematosus Antonis Fanouriakis, George Bertsias
19 January 2024
First use of cenerimod, a selective S1P1 receptor modulator, for the treatment of SLE: a double-blind, randomised, placebo-controlled, proof-of-concept study Viktoria Hermann, Anastas Batalov, Svetlana Smakotina, Pierre-Eric Juif, Peter Cornelisse
19 January 2024
Multiple polygenic risk scores can improve the prediction of systemic lupus erythematosus in Taiwan Yu-Chia Chen, Ting-Yuan Liu, Hsing-Fang Lu, Chung-Ming Huang, Chi-Chou Liao, Fuu-Jen Tsai
9 May 2024
Prevalence of coeliac disease in patients with systemic lupus erythematosus: a systematic review and meta-analysis Adonis Sotoodeh, Madeleine Nguyen Hoang, Karin Hellgren, Anders Forss
13 February 2024
Clinical implications of discordance between anti-dsDNA antibodies by multiplex flow immunoassay and Crithidia luciliae assay in a multiethnic racial cohort of patients with SLE Devyn Zaminski, Amit Saxena, Peter Izmirly, Jill P Buyon, H Michael Belmont
14 November 2023
Intercurrent infection as a risk factor for disease flares in patients with systemic lupus erythematosus Fatma el Hadiyen, Michel W P Tsang-A-Sjoe, Birgit I Lissenberg-Witte, Alexandre E Voskuyl, Irene E M Bultink
1 July 2024
Effects of systemic lupus erythematosus on the brain: a systematic review of structural MRI findings and their relationships with cognitive dysfunction Diana Valdés Cabrera, Tala El Tal, Ibrahim Mohamed, Santiago Eduardo Arciniegas, Stephanie Fevrier, Justine Ledochowski, Andrea M Knight
17 August 2024
Improving resource utilisation in SLE drug development through innovative trial design Sandra Garces, Elaine Karis, Joan T Merrill, Anca D Askanase, Kenneth Kalunian, May Mo, Cassandra E Milmont
16 February 2024
SLESIS-R: an improved score for prediction of serious infection in patients with systemic lupus erythematosus based on the RELESSER prospective cohort Iñigo Rua-Figueroa, M Jesus García de Yébenes, Julia Martinez-Barrio, Maria Galindo Izquierdo, Jaime Calvo Alén, Antonio Fernandez-Nebro, Raúl Menor-Almagro, Loreto Carmona, Beatriz Tejera Segura, Eva Tomero, Mercedes Freire-González, Clara Sangüesa, Loreto Horcada, Ricardo Blanco, Esther Uriarte ItzazelaiaSee the full list of authors
8 April 2024